MedTrace Logo

Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers

NCT02325271 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-09-06

No results posted yet for this study

Summary

The study evaluates the intra-individual variability of VEGF levels over a period of 6 months as well as the circadian variation of VEGF levels, both under standardized conditions in patients with type 2 diabetes without DME and matched subjects with normal glucose tolerance (NGT). Secondary objectives of the study are to evaluate the relationship of individual VEGF-levels to biomarkers of inflammation, HbA1c and major cardiovascular risk factors.

Conditions

Interventions

OTHER

Frequent blood and urine sampling and blood pressure measurement

Blood and urine sampling for the determination of VEGF and biomarkers

Sponsors & Collaborators

  • Novartis

    collaborator INDUSTRY

  • GWT-TUD GmbH

    lead OTHER

Principal Investigators

  • Markolf Hanefeld, Prof. Dr. · Study center Prof. Hanefeld, GWT-TUD GmbH

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-10-31
Completion
2016-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02325271 on ClinicalTrials.gov